This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

The automakers are using software and AI to make vehicles of tomorrow more collaborative, working alongside passengers. The Singapore-based company expects to raise $2.58 billion from the sale of its ...

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

Trump’s tariff warning has created shockwaves through India’s pharmaceutical industry, which supplied almost half of ...

A JetBlue pilot from Ohio was arrested at Logan International Airport in Boston Thursday night before he was scheduled to ...

Home care workers aren't getting an increase in their pay under Governor JB Pritzker's proposed budget. Rachel Maddow breaks ...

UnitedHealth Group slid after The Wall Street Journal reported that the Department of Justice was probing the insurance giant's Medicare billing practices. The company, which had already faced a ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid ... the active ingredient found in Ozempic and ...

One of the scariest moments of my life happened in 2022 when my father, Tom Donvito, then 75 and unaware of any allergies, experienced an anaphylactic reaction to a hornet sting. After he passed ...